Stocktoria

Equillium, Inc. EQ

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-10-12 · LEI

Equillium, Inc. statistics & valuation

Market cap$192.8M
P / B6.7×
Return on equity-78.3%
Return on capital-81.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
-393.90% -40.20% -20.10% 20182019202020212022202320242025
Return on equity (%)
-20.40% -61.20% -42.70% -58.70% -195.40% -59.10% -42.30% -78.30% 20182019202020212022202320242025
Shares outstanding
17.4M 17.4M 24.8M 29.5M 34.4M 35.3M 35.6M 61.5M 20182019202020212022202320242025
Net debt ($)
-$3.5M -$14.0M -$40.2M -$50.0M 20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-19.70% -46.10% -34.90% -45.70% -79.60% -26.40% -31.50% -70.20% 20182019202020212022202320242025
Free cash flow margin (%)
-57.20% -60.50% -46.50% 20182019202020212022202320242025
Debt / equity (×)
0.23× 0.14× 0.15× 0.28× 20182019202020212022202320242025
EPS ($)
-$1.36 -$1.85 -$0.38 -$0.23 -$0.39 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin—-20.1%-40.2%-393.9%————
Net margin—-19.6%-37.0%-396.1%————
FCF margin—-46.5%-60.5%-57.2%————
Return on assets-70.2%-31.5%-26.4%-79.6%-45.7%-34.9%-46.1%-19.7%
Return on equity-78.3%-42.3%-59.1%-195.4%-58.7%-42.7%-61.2%-20.4%
Debt / equity———0.28×0.15×0.14×0.23×—
Current ratio10.583.931.792.409.3511.7614.2833.09

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.